Back

Anti-heart autoantibodies and arrhythmogenic cardiomyopathy: the role of inflammation in disease evolution

28 August 2018 (15:01 - 15:15)
Organised by:
Congress Presentation Part of: Arrhythmogenic cardiomyopathy: From pathology to prognosis Arrhythmogenic Right Ventricular Cardiomyopathy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Geza Halasz

S. Camillo-Forlanini Hospital, Rome (Italy)

4 More presentations in this session

Presentation thumbnail
Pathogenesis of ARVC - State of the art
Professor E. Arbustini (Pavia, IT)
Slides Video
Presentation thumbnail
Arrhythmogenic cardiomyopathy: a paradigm shift of the morphologic spectrum
Doctor M. De Gaspari (Padova, IT)
Abstract Slides Video
Presentation thumbnail
Multimodality prediction of life-threatening ventricular arrhythmia in patients with arrhythmogenic cardiomyopathy; a prospective cohort study
Doctor O. Lie (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Treatment of ARVC: current standards and future perspectives
Professor T. Wichter (Osnabrueck, DE)
Slides Video

Access the full session

Session thumbnail
Arrhythmogenic cardiomyopathy: From pathology to prognosis

The Event

Event poster

ESC Congress 2018

28 August 2018 15:01 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources